Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.43 |
| ▸ | GPR119 | Q8TDV5 | 14/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | WDR5 | P61964 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.36 |
| ▸ | EIF4E | P06730 | 2/20 | 0.36 |
| ▸ | MKNK1 | Q9BUB5 | 2/20 | 0.36 |
| ▸ | MKNK2 | Q9HBH9 | 2/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1066161 | 0.83 | GPR119 (0.58) | GPR119CYP2C9 | |
| SCHEMBL3716443 | 0.70 | GPR119 (0.47) | GPR119CYP2C9 | |
| SCHEMBL8647897 | 0.69 | EGFR (0.67) | HTTSMN1; SMN2 | |
| SCHEMBL12236499 | 0.69 | HRH4 (0.43) | HTT | |
| SCHEMBL288618 | 0.69 | GPR119 (0.75) | GPR119CYP2C9 | |
| SCHEMBL16701160 | 0.68 | SMN1; SMN2 (0.45) | HTTSMN1; SMN2KMT2A | |
| SCHEMBL12236467 | 0.68 | HRH1 (0.43) | GPR119 | |
| SCHEMBL761736 | 0.67 | GPR119 (0.58) | GPR119CYP2C9 | |
| SCHEMBL3304134 | 0.66 | ALDH1A1 (0.54) | WDR5KMT2ACYP3A4CYP2C19 | |
| SCHEMBL3181260 | 0.66 | ALDH1A1 (0.39) | IRAK4HTTSMN1; SMN2KMT2ACYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2445901-A1 | NEW COMPOUNDS, PHARMACEUTICAL COMPOSITION AND METHODS RELATING THERETO | Boehringer Ingelheim International GmbH (DE) | 2012-05-02 | — | — | EP | disclosed |
| WO-2010149685-A1 | NEW COMPOUNDS, PHARMACEUTICAL COMPOSITION AND METHODS RELATING THERETO | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2010-12-29 | — | — | WO | disclosed |